The Journal of Nutritional Biochemistry
Volume 20, Issue 12 , Pages 992-999 , December 2009

Chromium supplement inhibits skeletal muscle atrophy in hindlimb-suspended mice

  • Feng Dong

      Affiliations

    • School of Pharmacy, Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, Laramie, WY 82071, USA
    • F. Dong and Y. Hua share equal first authorship.
    • ,
  • Yinan Hua

      Affiliations

    • School of Pharmacy, Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, Laramie, WY 82071, USA
    • F. Dong and Y. Hua share equal first authorship.
    • ,
  • Peng Zhao

      Affiliations

    • School of Pharmacy, Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, Laramie, WY 82071, USA
    • ,
  • Jun Ren

      Affiliations

    • School of Pharmacy, Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, Laramie, WY 82071, USA
    • ,
  • Min Du

      Affiliations

    • Animal Sciences Department, Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, Laramie, WY 82071, USA
    • ,
  • Nair Sreejayan

      Affiliations

    • School of Pharmacy, Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, Laramie, WY 82071, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 307 766 6138; fax: +1 307 766 2953.

Received 26 July 2008 ,Revised 3 September 2008 ,Accepted 5 September 2008.

References 

  1. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol. 2004;287:C834–C843
  2. Thomason DB, Booth FW. Atrophy of the soleus muscle by hindlimb unweighting. J Appl Physiol. 1990;68:1–12
  3. Tisdale MJ. Cancer cachexia: metabolic alterations and clinical manifestations. Nutrition. 1997;13:1–7
  4. Krasnoff J, Painter P. The physiological consequences of bed rest and inactivity. Adv Ren Replace Ther. 1999;6:124–132
  5. Pavy-Le Traon A, Heer M, Narici MV, Rittweger J, Vernikos J. From space to Earth: advances in human physiology from 20 years of bed rest studies (1986–2006). Eur J Appl Physiol. 2007;101:143–194
  6. Karakelides H, Nair KS. Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol. 2005;68:123–148
  7. Rogers MA, Evans WJ. Changes in skeletal muscle with aging: effects of exercise training. Exerc Sport Sci Rev. 1993;21:65–102
  8. Edgerton VR, Zhou MY, Ohira Y, Klitgaard H, Jiang B, Bell G, et al. Human fiber size and enzymatic properties after 5 and 11 days of spaceflight. J Appl Physiol. 1995;78:1733–1739
  9. Grigoriev AI, Egorov AD. Physiological aspects of adaptation of main human body systems during and after spaceflights. Adv Space Biol Med. 1992;2:43–82
  10. Loughna P, Goldspink G, Goldspink DF. Effect of inactivity and passive stretch on protein turnover in phasic and postural rat muscles. J Appl Physiol. 1986;61:173–179
  11. Eash J, Olsen A, Breur G, Gerrard D, Hannon K. FGFR1 inhibits skeletal muscle atrophy associated with hindlimb suspension. BMC Musculoskelet Disord. 2007;8:32
  12. Alzghoul MB, Gerrard D, Watkins BA, Hannon K. Ectopic expression of IGF-I and Shh by skeletal muscle inhibits disuse-mediated skeletal muscle atrophy and bone osteopenia in vivo. Faseb J. 2004;18:221–223
  13. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977;30:531–538
  14. Freund H, Atamian S, Fischer JE. Chromium deficiency during total parenteral nutrition. JAMA. 1979;241:496–498
  15. Hummel M, Standl E, Schnell O. Chromium in metabolic and cardiovascular disease. Horm Metab Res. 2007;39:743–751
  16. Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus — a review. Diabetes Technol Ther. 2006;8:677–687
  17. van de Laar FA, Akkermans RP, van Binsbergen JJ. Limited evidence for effects of diet for type 2 diabetes from systematic reviews. Eur J Clin Nutr. 2007;61:929–937
  18. Kleefstra N, Houweling ST, Bakker SJ, Verhoeven S, Gans RO, Meyboom-de Jong B, et al. Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2007;30:1092–1096
  19. Mondon CE, Rodnick KJ, Dolkas CB, Azhar S, Reaven GM. Alterations in glucose and protein metabolism in animals subjected to simulated microgravity. Adv Space Res. 1992;12:169–177
  20. Hirose M, Kaneki M, Sugita H, Yasuhara S, Martyn JA. Immobilization depresses insulin signaling in skeletal muscle. Am J Physiol Endocrinol Metab. 2000;279:E1235–E1241
  21. O'Keefe MP, Perez FR, Kinnick TR, Tischler ME, Henriksen EJ. Development of whole-body and skeletal muscle insulin resistance after one day of hindlimb suspension. Metabolism. 2004;53:1215–1222
  22. Morey-Holton E, Wronski TJ. Animal models for simulating weightlessness. Physiologist. 1981;24:S45–S48
  23. Adams GR, Caiozzo VJ, Baldwin KM. Skeletal muscle unweighting: spaceflight and ground-based models. J Appl Physiol. 2003;95:2185–2201
  24. Talmadge RJ, Roy RR, Edgerton VR. Distribution of myosin heavy chain isoforms in non-weight-bearing rat soleus muscle fibers. J Appl Physiol. 1996;81:2540–2546
  25. Edgerton VR, Roy RR. Spaceflight experiments and international collaborations. J Gravit Physiol. 1998;5:P185–P187
  26. Fitts RH, Riley DR, Widrick JJ. Physiology of a microgravity environment invited review: microgravity and skeletal muscle. J Appl Physiol. 2000;89:823–839
  27. Hilder TL, Tou JC, Grindeland RE, Wade CE, Graves LM. Phosphorylation of insulin receptor substrate-1 serine 307 correlates with JNK activity in atrophic skeletal muscle. FEBS Lett. 2003;553:63–67
  28. Hilder TL, Baer LA, Fuller PM, Fuller CA, Grindeland RE, Wade CE, et al. Insulin-independent pathways mediating glucose uptake in hindlimb-suspended skeletal muscle. J Appl Physiol. 2005;99:2181–2188
  29. Yang X, Palanichamy K, Ontko AC, Rao MN, Fang CX, Ren J, et al. A newly synthetic chromium complex: chromium(phenylalanine)3 improves insulin responsiveness and reduces whole body glucose tolerance. FEBS Lett. 2005;579:1458–1464
  30. Park E, Schultz E. A simple hindlimb suspension apparatus. Aviat Space Environ Med. 1993;64:401–404
  31. Li SY, Yang X, Ceylan-Isik AF, Du M, Sreejayan N, Ren J. Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch. Diabetologia. 2006;49:1434–1446
  32. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. Faseb J. 2004;18:39–51
  33. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004;117:399–412
  34. Brown RO, Forloines-Lynn S, Cross RE, Heizer WD. Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci. 1986;31:661–664
  35. Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. In Diabetes. 1997;46:1786–1791
  36. Martin J, Wang ZQ, Zhang XH, Wachtel D, Volaufova J, Matthews DE, et al. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care. 2006;29:1826–1832
  37. Vincent JB. The biochemistry of chromium. J Nutr. 2000;130:715–718
  38. Wang H, Kruszewski A, Brautigan DL. Cellular chromium enhances activation of insulin receptor kinase. Biochemistry. 2005;44:8167–8175
  39. Cefalu WT, Hu FB. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004;(Suppl):2–14
  40. Sharma M, Langley B, Bass J, Kambadur R. Myostatin in muscle growth and repair. Exerc Sport Sci Rev. 2001;29:155–158
  41. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387:83–90
  42. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, et al. Induction of cachexia in mice by systemically administered myostatin. Science. 2002;296:1486–1488
  43. Carlson CJ, Booth FW, Gordon SE. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol. 1999;277:R601–R606
  44. McMahon CD, Popovic L, Oldham JM, Jeanplong F, Smith HK, Kambadur R, et al. Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension. Am J Physiol Endocrinol Metab. 2003;285:E82–E87
  45. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A. 2001;98:14440–14445
  46. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001;294:1704–1708
  47. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001;3:1014–1019
  48. Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest. 2000;106:165–169
  49. Lee YH, Giraud J, Davis RJ, White MF. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem. 2003;278:2896–2902

PII: S0955-2863(08)00212-X

doi: 10.1016/j.jnutbio.2008.09.006

The Journal of Nutritional Biochemistry
Volume 20, Issue 12 , Pages 992-999 , December 2009

Article Tools

* Image Usage & Resolution